Is health-related quality of life of patients after single-use flexible ureteroscopy superior to extracorporeal shock wave lithotripsy? A randomised prospective study
Language English Country Germany Media print-electronic
Document type Journal Article, Randomized Controlled Trial, Validation Study
PubMed
33164114
DOI
10.1007/s00240-020-01224-4
PII: 10.1007/s00240-020-01224-4
Knihovny.cz E-resources
- Keywords
- ESWL, HRQOL, RIRS, Ureteroscopy, Urinary stone disease,
- MeSH
- Quality of Life * MeSH
- Quality-Adjusted Life Years MeSH
- Middle Aged MeSH
- Humans MeSH
- Lithotripsy statistics & numerical data MeSH
- Urinary Calculi complications psychology surgery MeSH
- Translating MeSH
- Prospective Studies MeSH
- Surveys and Questionnaires statistics & numerical data MeSH
- Psychometrics methods MeSH
- Reproducibility of Results MeSH
- Aged MeSH
- Ureteroscopy instrumentation statistics & numerical data MeSH
- Ureteroscopes MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Randomized Controlled Trial MeSH
- Validation Study MeSH
The aims of the study were to compare the change in the Wisconsin Stone Quality of Life (WISQOL) score in patients who underwent retrograde intrarenal surgery (RIRS) single-use ureteroscope or extracorporeal shock wave lithotripsy (ESWL) with a calculation of quality-adjusted life-years (QALYs). 158 patients treated with urinary stone disease were randomly divided into 80 patients in the validation and 78 patients in the intervention arm. Patients in the intervention arm were randomly divided into the RIRS or the ESWL group. Linguistic validation of the WISQOL into the Slovak language was performed using a standardised multistep process. Discriminant validity was assessed by comparing stone-forming patients to an additional 34 healthy individuals. Patients were asked to fill in the WISQOL before and in the 24th week after the intervention. The QALYs were calculated by the formula QALY = weight factor (WF) x time period after intervention. The Cronbach's α of the WISQOL was 0.94, the Pearson's coefficient for test-retest reliability was 0.91, and the discriminant validity confirmed a higher score for healthy individuals (p < 0.001). The median WISQOL score changed from 45.5 to 95.5 vs. 33.9 to 87.1 in the RIRS and ESWL groups, respectively (p < 0.001). Patients from the RIRS group had a good possibility of reaching 19.727 QALYs gained during life expectancy compared to 15.780 for the ESWL group (p < 0.001). RIRS single-use ureteroscope is significantly superior to ESWL in reaching more QALYs gained during life expectancy. The WISQOL Slovak version is valid, reliable and strictly specific for stone-forming patients.
See more in PubMed
New F, Somani BK (2016) A complete world literature review of quality of life (QOL) in patients with kidney stone disease (KSD). Curr Urol Rep 17(12):88 DOI
Penniston KL, Antonelli JA, Viprakasit DP, Averch TD, Sivalingam S, Sur RL, Pais VM Jr, Chew BH, Bird VG, Nakada SY (2017) Validation and reliability of the Wisconsin stone quality of life questionnaire. J Urol 197(5):1280–1288 DOI
Atalay HA, Ulker V, Canat L, Murat O, Can O, Penniston KL (2018) Validation of the Turkish version of the Wisconsin stone-quality of life questionnaire. Turk J Urol 45(2):118–123 DOI
Basulto-Martínez M, Olvera-Posada D, Velueta-Martínez IA, Méndez-Probst C, Flores-Tapia JP, Penniston K, Guerrero-Putz MD, Heinze A (2020) Quality of life in patients with kidney stones: translation and validation of the Spanish Wisconsin Stone Quality of Life Questionnaire. Urolithiasis 48(5):419–424 DOI
Marseille E, Larson B, Kazi DS, Kahn JG, Rosen S (2015) Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organ 93(2):118–124 DOI
Alken P (2018) Intracorporeal lithotripsy. Urolithiasis 46(1):19–29 DOI
Geraghty RM, Jones P, Herrmann TRW, Aboumarzouk O, Somani BK (2018) Ureteroscopy is more cost effective than shock wave lithotripsy for stone treatment: systematic review and meta-analysis. World J Urol 36(11):1783–1793 DOI
Hutchinson A, Bentzen N, König-Zahn C (1996) Cross-cultural health outcome assessment: a user’s guide. European Research Group on Health Outcomes, Ruinen
Statistical Office of the Slovak Republic (2020) Statistiky—Demografia a socialne statistiky—Obyvatelstvo a migracia—Ukazovatele—Tabulky zivota—Zdrave roky zivota podla EU SILC, 2005–2018 (in Slovak language). http://datacube.statistics.sk/#!/view/sk/VBD_SLOVSTAT/om2021rs/v_om2021rs_00_00_00_sk Accessed 14 Mar 2020
Hesse A, Brändle E, Wilbert D, Köhrmann KU, Alken P (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 44(6):709–713 DOI
Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63(5):1817–1823 DOI
Angell J, Bryant M, Tu H, Goodman M, Pattaras J, Ogan K (2012) Association of depression and urolithiasis. Urology 79(3):518–525 DOI
El-Nahas AR, Ibrahim HM, Youssef RF, Sheir KZ (2012) Flexible ureterorenoscopy versus extracorporeal shock wave lithotripsy for treatment of lower pole stones of 10–20 mm. BJU Int 110(6):898–902 DOI
Fankhauser ChD, Hermanns T, Lieger L, Diethelm O, Umbehr M, Luginbuhl T, Sulser T, Muntener M, Poyet C (2018) Extracorporeal shock wave lithotripsy versus flexible ureterorenoscopy in the treatment of untreated renal calculi. Clin Kidney J 11(3):364–369 DOI
Desai M, Sun Y, Buchholz N, Fuller A, Matsuda T, Matlaga B, Miller N, Bolton D, Alomar M, Ganpule A (2017) Treatment selection for urolithiasis: percutaneous nephrolithotomy, ureteroscopy, shock wave lithotripsy, and active monitoring. World J Urol 35(9):1395–1399 DOI
Shen P, Jiang M, Yang J, Li X, Li Y, Wei W, Dai Y, Zeng H, Wang J (2011) Use of ureteral stent in extracorporeal shock wave lithotripsy for upper urinary calculi: a systematic review and meta-analysis. J Urol 186(4):1328–1335 DOI